The prevalence of kidney diseases across the globe has been increasing at a rapid pace. Some of the major risk factors for kidney diseases are human immunodeficiency virus, malaria, diarrhoeal diseases, low birth weight, and preterm birth. As per the World Health Organization, about 1.2 million people died due to kidney failure in 2015. Furthermore, an estimated number of 5–10 million people die each year because of kidney failure around the world. Chronic kidney diseases result in hospitalization, poor life quality, and cognitive dysfunction. Since apheresis therapies are utilized for the treatment of kidney diseases, their demand has been increasing swiftly.
 |
| To Learn more about this report: https://bit.ly/2AYBxHQ |
Under the apheresis procedure, whole blood from a patient or donor is removed, which is then separated into individual components in order to remove one particular component. The remaining components are later re-introduced into the bloodstream of the donor or patient. This medical procedure is also utilized for collecting donor blood components, including plasma or platelets, along with treating diseases, such as kidney diseases. Owing to these factors, the global apheresis market is expected to advance at a significant pace in the years to come.
Geographically, North America has been the major user of apheresis systems up till now, which is because of the increasing number of cancer cases, renal & liver failure, and heart diseases. For example, as per a 2018 study by the Centers for Disease Control and Prevention, owing to sedentary life, over 647,000 people die in the U.S. each year. Other than this, the demand for apheresis is expected to increase significantly in Asia-Pacific, thereby making it the fastest-growing apheresis market in the coming years. This is owing to technological advancements and rising health concerns in the region.
In conclusion, the demand for apheresis systems is growing due to the surging number of kidney diseases across the globe.
No comments:
Post a Comment